We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current XVIPF market cap is 1.35B. The company's latest EPS is SEK 2.9150 and P/E is 14.67.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | |
| Total Revenue | 220.84M | 179.86M | 258.39M | 415.29M | 597.54M |
| Operating Income | 3.97M | -44.19M | -18.74M | 4.46M | 5.4M |
| Net Income | 4.94M | -43.74M | 8.15M | 18.43M | 91.82M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | |
| Total Assets | 634.49M | 1.15B | 1.54B | 1.73B | 2.2B |
| Total Liabilities | 56.97M | 141.85M | 257.15M | 302.95M | 250.57M |
| Total Equity | 577.52M | 1.01B | 1.29B | 1.43B | 1.95B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | |
| Operating | 29.51M | -12.27M | -12.06M | 27.86M | 46.29M |
| Investing | -83.84M | -266.53M | -187.7M | -197.62M | -161.62M |
| Financing | 25.55M | 482.77M | 234.61M | -6.84M | 418.55M |
| Market Cap | 1.35B |
| Price to Earnings Ratio | 14.67 |
| Price to Sales Ratio | 2.25 |
| Price to Cash Ratio | 5.47 |
| Price to Book Ratio | 0.69 |
| Dividend Yield | - |
| Shares Outstanding | 31.5M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 278 |
| 52 Week Change | 57.50% |
| 52 Week High | 43.11 |
| 52 Week Low | 19.90 |
| Spread (Intraday) | 1.32 (3.28%) |
| Company Name | Xvivo Perfusion AB (PK) |
| Address |
massans gata 10 goteborg SE-400 14 |
| Website | https://www.xvivoperfusion.com |
| Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
